The efficacy, safety and carry-over effect of diacerein in the treatment of painful knee osteoarthritis: a randomised, double-blind, NSAID-controlled study

Osteoarthritis and Cartilage

Volumn 15, Issue 6, 2007, Pages 605-614

  Louthrenoo, W ^a   Nilganuwong, S ^a   Aksaranugraha, S ^b   Asavatanabodee, P ^c   Saengnipanthkul, S ^d   the Thai Study Group, ^e  

^a THAMMASAT UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c PRAMONGKUTKLAO HOSPITAL   (Thailand)

^d KHON KAEN UNIVERSITY   (Thailand)

^e NONE

Author keywords

Diacerein; NSAID; Osteoarthritis; Piroxicam; RCT; SYSADOA

Indexed keywords

DIACETYLRHEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM; PLACEBO;

ABDOMINAL PAIN; ADULT; AGED; ARTHROPATHY; ARTICLE; ASTHENIA; BLOOD ANALYSIS; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; EDEMA; FEMALE; FUNCTIONAL STATUS; GASTRITIS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERTENSION; INTESTINAL DYSMOTILITY; KNEE OSTEOARTHRITIS; KNEE PAIN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCULOSKELETAL DISEASE; MYALGIA; NAUSEA; NEUROLOGIC DISEASE; PARALLEL DESIGN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SHORT FORM 36; SIDE EFFECT; STATISTICAL ANALYSIS; THAILAND; UPPER RESPIRATORY TRACT INFECTION; URINALYSIS; URINARY TRACT DISEASE; VITAL SIGN;

ADULT; AGED; ANTHRAQUINONES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PIROXICAM; THAILAND;

EID: 34249081855     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2007.02.021     Document Type: Article

References (34)

1. Altman R.D., Abramson S., Bruyere O., Clegg D., Herrero-Beaumont G., Maheu E., et al. Commentary: osteoarthritis of the knee and glucosamine. Osteoarthritis Cartilage 14 (2006) 963-966
2. Kuptniratsaikul V., Tosayanonda O., Nilganuwong S., and Thamalikitkul V. The epidemiology of osteoarthritis of the knee in elderly patients living an urban area of Bangkok. J Med Assoc Thai 85 (2002) 154-161
3. Pelletier J.P., DiBattista J.A., Roughley P., McCollum R., and Martel-Pelletier J. Cytokines and inflammation in cartilage degradation. Rheum Dis Clin North Am 19 (1993) 545-568
4. Pelletier J.P., and Martel-Pelletier J. Therapeutic targets in osteoarthritis: from today to tomorrow with new imaging technology. Ann Rheum Dis 62 Suppl 2 (2003) ii79-ii82
5. Moldovan F., Pelletier J.-P., Jolicoeur F.C., Cloutier J.M., and Martel-Pelletier J. Diacerhein and rhein reduce the ICE-induced IL-1β and IL-18 activation in human osteoarthritic cartilage. Osteoarthritis Cartilage 8 (2000) 186-196
6. Yaron M., Shirazi I., and Yaron I. Anti-interleukin-1 effects of diacerein and rhein in human osteoarthritic synovial tissue and cartilage cultures. Osteoarthritis Cartilage 7 (1999) 272-280
7. Lequesne M. Symptomatic slow-acting drugs in osteoarthritis: a novel therapeutic concept?. Rev Rhum Engl Ed 61 (1994) 69-73
8. Kellgren J.H., and Lawrence J.S. Radiological assessment of osteoarthrosis. Ann Rheum Dis 16 (1957) 494-502
9. Altman R., Asch E., Bloch D., Bole G., Borenstein D., Brandt K., et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum 29 (1986) 1039-1049
10. International Conference on Harmonisation of Technical. Requirements for Registration of Pharmaceuticals for Human Use (ICH). Topic E9. Statistical principles for clinical trials. Step 4. Consensus Guidelines. February 5. 1998: CPMP Ref. CPMP/ICH/363-96.
11. Colditz G.A., Miller J.N., and Mosteller F. Measuring gain in the evaluation of medical technology. The probability of a better outcome. Int J Technol Assess Health Care 4 (1988) 637-642
12. Nguyen M., Dougados M., Berdah L., and Amor B. Diacerhein in the treatment of osteoarthritis of the hip. Arthritis Rheum 37 (1994) 529-536
13. Zheng W.J., Tang F.L., Li J., Zhang F.C., Li Z.G., Su Y., et al. Efficacy and safety of diacerein in osteoarthritis of the knee: a randomized, multicenter, double-dummy, diclofenac-controlled trial in China. APLAR J Rheumatol 9 (2006) 64-69
14. Marcolongo R., Fioravanti A., Adami S., Tozzi E., Mian M., and Zampieri A. Efficacy and tolerability of Diacerhein in the treatment of osteoarthrosis. Curr Ther Res 43 (1988) 878-887
15. Pelletier J.P., Yaron M., Haraoui B., Cohen P., Nahir M.A., Choquette D., et al. Efficacy and safety of diacerein in osteoarthritis of the knee: a double-blind, placebo-controlled trial. The Diacerein Study Group. Arthritis Rheum 43 (2000) 2339-2348
16. Dougados M., Nguyen M., Berdah L., Mazieres B., Vignon E., and Lequesne M. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Arthritis Rheum 44 (2001) 2539-2547
17. Jones A.C., and Doherty M. The treatment of osteoarthritis. Br J Clin Pharmacol 33 (1992) 357-363
18. Huskisson E.C., Berry H., Gishen P., Jubb R.W., and Whitehead J. Effects of antiinflammatory drugs on the progression of osteoarthritis of the knee. LINK Study Group. Longitudinal Investigation of nonsteroidal antiinflammatory drugs in knee osteoarthritis. J Rheumatol 22 (1995) 1941-1946
19. Juni P., Nartey L., Reichenbach S., Sterchi R., Dieppe P.A., and Egger M. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 364 (2004) 2021-2029
20. Horton R. Vioxx, the implosion of Merck, and aftershocks at the FDA. Lancet 364 (2004) 1995-1996
21. Martel-Pelletier J., Mineau F., Jolicoeur F.C., Cloutier J.M., and Pelletier J.P. In vitro effects of diacerhein and rhein on interleukin 1 and tumor necrosis factor-alpha systems in human osteoarthritic synovium and chondrocytes. J Rheumatol 25 (1998) 753-762
22. Ferreira-Mendes A.F., Caramona M.M., de Carvalho A.P., and Lopes M.C. Diacerhein and rhein prevent interleukin-1beta-induced nuclear factor-kappaB activation by inhibiting the degradation of inhibitor kappaB-alpha. Pharmacol Toxicol 91 (2002) 22-28
23. Felisaz N., Boumediene K., Ghayor C., Herrouin J.F., Bogdanowicz P., Galerra P., et al. Stimulating effect of diacerein on TGF-β1 and β2 expression in articular chondrocytes cultured with and without interleukin-1. Osteoarthritis Cartilage 7 (1999) 255-264
24. Douni E., Sfikakis P.P., Haralambous S., Fernandes P., and Kollias G. Attenuation of inflammatory polyarthritis in TNF transgenic mice by diacerein: comparative analysis with dexamethasone, methotrexate and anti-TNF protocols. Arthritis Res Ther 6 (2004) R65-R72
25. Smith Jr. G.N., Myers S.L., Brandt K.D., Mickler E.A., and Albrecht M.E. Diacerhein treatment reduces the severity of osteoarthritis in the canine cruciate-deficiency model of osteoarthritis. Arthritis Rheum 42 (1999) 545-554
26. Brandt K.D., Smith G., Kang S.Y., Myers S., O'Connor B., and Albrecht M. Effects of diacerhein in an accelerated canine model of osteoarthritis. Osteoarthritis Cartilage 5 (1997) 438-449
27. Ghosh P., Xu A., Hwa S.Y., Burkhardt D., and Little C. [Evaluation of the effects of diacerhein in the sheep model of arthritis]. Rev Prat 48 Suppl 17 (1998) S24-S30
28. Mazieres B., and Berda L. Effect of diacerhein (ART 50) on an experimental post-contusive model of OA. Osteoarthritis Cartilage 1 (1993) 47
29. Lequesne M., Berdah L., and Gerentes I. [Efficacy and tolerance of diacerhein in the treatment of gonarthrosis and coxarthrosis]. Rev Prat 48 Suppl 17 (1998) S31-S35
30. Pelletier J.P., Mineau F., Fernandes J.C., Duval N., and Martel-Pelletier J. Diacerhein and rhein reduce the interleukin 1β stimulated inducible nitric oxide synthesis level and activity while stimulating cyclooxygenase-2 synthesis in human osteoarthritic chondrocytes. J Rheumatol 25 (1998) 2417-2424
31. Nicolas P., Tod M., Padoin C., and Petitjean O. Clinical pharmacokinetics of diacerein. Clin Pharmacokinet 35 (1998) 347-359
32. Fidelix T.S.A., Soares B.G.D.O., and Trevisani V.F.M. Diacerein for osteoarthritis (Review). Cochrane Database Syst Rev 1 (2006) 1-59
33. Rintelen B., Neumann K., and Leeb B.F. A meta-analysis of controlled clinical studies with diacerein in the treatment of osteoarthritis. Arch Intern Med 166 (2006) 1899-1906
34. Petrillo M., Montrone F., Ardizzone S., Caruso I., and Bianchi-Porro G. Endoscopic evaluation of Diacethylrhein-induced gastric mucosal lesions. Curr Ther Res 49 (1991) 10-15